Indian companies have announced a historic commitment to invest $20.5 billion in the United States, with the pharmaceutical sector accounting for a substantial $19.1 billion of that total, as reported by the US embassy on Wednesday.
The investment pledges were unveiled during a summit focused on investment held in Maryland.
As per the US embassy’s announcement, these investments will cover various vital sectors such as pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies. This influx of capital is anticipated to generate thousands of jobs in both nations and enhance production capabilities and collaborative innovation in the US.
Ambassador Sergio Gor expressed pride in the progress towards the objective of doubling US-India bilateral trade to $500 billion by 2030. He emphasized that fair and mutually beneficial trade is attracting top-tier investments to the US, fostering shared prosperity for both countries.
A significant portion of the pledged investment is attributed to India’s pharmaceutical industry, with over $19.1 billion earmarked for manufacturing, research and development, and the establishment of new facilities in the US.
Moreover, twelve Indian firms have declared investments exceeding $1.1 billion for new projects and expansions across various states, contributing to job creation in manufacturing, technology, and engineering sectors.
Major contributions from Indian pharmaceutical companies include Sun Pharmaceutical’s proposed $11.75 billion acquisition of Organon & Co., based in New Jersey. Other participating firms encompass Aurobindo Pharma Ltd, Biocon Group, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Ltd, and Zydus Lifesciences Ltd, as detailed in the statement.
These investments aim to bolster manufacturing capabilities, expand networks, establish new facilities, and enhance research and development efforts, ultimately increasing the availability of essential medications and fortifying the resilience of the US healthcare supply chain.
JSW Steel has confirmed intentions to invest $255 million in modernization projects at its facilities located in Ohio and Texas.
Abhyuday Group from Ahmedabad is set to invest over $900 million across five sites in the US, creating approximately 1,500 jobs. Jindal Pipe and Jindal Tubular USA (PR Jindal Group) plan to invest $87 million for expansions in Texas and Mississippi, generating 140 jobs. Jivo Wellness from Delhi will contribute $15 million, resulting in 50 direct jobs and an additional 150 indirect jobs. Polyhose Inc. will invest $2 million in Los Angeles to support the shipbuilding sector.
Sterlite Technologies Ltd, based in Mumbai, plans to invest $100 million, which is expected to create up to 500 jobs while supporting artificial intelligence and telecommunications infrastructure.
Techdome Solutions from Indore aims to invest $7.5 million, leading to the creation of 100 jobs. RoshAi from Kerala will invest $5 million in Texas, providing 20 jobs. Chennai-based Atri AI plans to invest $2 million in Menlo Park, California, while Kissflow will invest $2 million in Houston. SatoriXR will contribute $1.5 million in Michigan, creating 25 jobs.
MagnoInnovation Lab from Kerala will invest $2 million to set up field operations in the US and support applications in the energy sector. Additionally, the Indian Institute of Technology Madras Global Research Foundation will allocate $4.5 million to establish a research and collaboration hub in California, with plans for a further facility on the East Coast.
Shubhajit Roy, a seasoned journalist with over 25 years of experience, has been with The Indian Express since October 2003, focusing on foreign affairs for more than 17 years. Stationed in Delhi, he has led the national government and political bureau at The Indian Express, overseeing the coverage of political affairs in India. Roy has received the Ramnath Goenka Journalism Award for Excellence in Journalism in 2016 for his coverage of the Holey Bakery attack in Dhaka and the ensuing events. He also earned the IIMCAA Award for Journalist of the Year in 2022 (Jury’s special mention) for his reporting on the fall of Kabul in August 2021, where he was one of the few Indian journalists present during the Taliban’s rise to power.
